Follicular helper T cell signature in type 1 diabetes

Journal of Clinical Investigation

Volumn 125, Issue 1, 2015, Pages 292-303

  Kenefeck, Rupert ^a   Wang, Chun Jing ^a   Kapadi, Tauseef ^b   Wardzinski, Lukasz ^a   Attridge, Kesley ^b   Clough, Louise E ^b   Heuts, Frank ^a   Kogimtzis, Alexandros ^a   Patel, Sapna ^b   Rosenthal, Miranda ^a   Ono, Masahiro ^c   Sansom, David M ^a   Narendran, Parth ^b   Walker, Lucy S K ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 2; INTERLEUKIN 21; LYMPHOCYTE SURFACE MARKER; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 6; AUTOANTIGEN; CXCR5 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLICULAR HELPER T CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HELPER CELL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE ACTIVATION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CASE CONTROL STUDY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPH NODE; LYMPHOCYTE ACTIVATION; METABOLISM; PANCREAS; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ADULT; ANIMALS; AUTOANTIGENS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; INTERLEUKINS; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE, INBRED BALB C; MICE, TRANSGENIC; PANCREAS; RECEPTORS, CXCR5; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTOME; UP-REGULATION;

EID: 84920409661     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76238     Document Type: Article

References (81)

1. Katz JD, Benoist C, Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 1995;268(5214):1185-1188.
2. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol. 1995;154(9):4874-4882.
3. Anderson JT, Cornelius JG, Jarpe AJ, Winter WE, Peck AB. Insulin-dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a TH2 and not a TH1 mediated event. Autoimmunity. 1993;15(2):113-122.
4. Han D, et al. Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clin Immunol. 2011;139(3):290-301.
5. Kallmann BA, et al. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes. 1997;46(2):237-243.
6. Mayer A, Rharbaoui F, Thivolet C, Orgiazzi J, Madec AM. The relationship between peripheral T-cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab. 1999;84(7):2419-2424.
7. Halminen M, Simell O, Knip M, Ilonen J. Cytok-ine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated autoantibodies. Scand J Immunol. 2001;53(5):510-513.
8. Durinovic-Bello I, et al. Pro-and anti-inflammatory cytokine production by autoimmune T-cells against preproinsulin in HLA-DRB1∗04, DQ8 type 1 diabetes. Diabetologia. 2004;47(3):439-450.
9. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T-cell-mediated tissue damage. Nat Med. 2007;13(2):139-145.
10. Ferraro A, et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011;60(11):2903-2913.
11. Arif S, et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated beta-cell death. Diabetes. 2011;60(8):2112-2119.
12. Joseph J, Bittner S, Kaiser FM, Wiendl H, Kissler S. IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes. J Immunol. 2012;188(1):216-221.
13. Kriegel MA, Sefik E, Hill JA, Wu HJ, Benoist C, Mathis D. Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2011;108(28):11548-11553.
14. Lau K, et al. Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol. 2011;186(6):3538-3546.
15. Korn T, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484-487.
16. Yang L, et al. IL-21 and TGF-β are required for differentiation of human T(H)17 cells. Nature. 2008;454(7202):350-352.
17. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A. 2008;105(37):14028-14033.
18. Sutherland AP, et al. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes. 2009;58(5):1144-1155.
19. Clough LE, et al. Release from regulatory T-cell-mediated suppression during the onset of tissue-specific autoimmunity is associated with elevated IL-21. J Immunol. 2008;180(8):5393-5401.
20. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet-cell antigens in the pancreatic lymph nodes. J Exp Med. 1999;189(2):331-339.
21. Chtanova T, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173(1):68-78.
22. Vinuesa CG, et al. A RING-type ubiquitin ligase family member required to repress follicular helper T-cells and autoimmunity. Nature. 2005;435(7041):452-458.
23. Nurieva RI, et al. Bcl6 mediates the development of T follicular helper cells. Science. 2009;325(5943):1001-1005.
24. Yu D, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457-468.
25. Liu X, et al. Bcl6 expression specifies the T fol-licular helper cell program in vivo. J Exp Med. 2012;209(10):1841-1852.
26. Ono M, Tanaka RJ, Kano M, Sugiman T. Visualising the cross-level relationships between pathological and physiological processes and gene expression: analyses of haematological diseases. PLoS One. 2013;8(1):e53544.
27. McGuire HM, et al. A subset of interleukin-21+ chemokine receptor CCR9+ T helper cells target accessory organs of the digestive system in auto-immunity. Immunity. 2011;34(4):602-615.
28. Morita R, et al. Human blood CXCR5(+)CD4(+) T-cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108-121.
29. Xu X, et al. Inhibition of increased circulating Tfh cell by anti-CD20 monoclonal antibody in patients with type 1 diabetes. PLoS One. 2013;8(11):e79858.
30. Luthje K, et al. The development and fate of fol-licular helper T-cells defined by an IL-21 reporter mouse. Nat Immunol. 2012;13(5):491-498.
31. Choi YS, et al. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity. 2011;34(6):932-946.
32. Pepper M, Pagan AJ, Igyarto BZ, Taylor JJ, Jenkins MK. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity. 2011;35(4):583-595.
33. Johnston RJ, Choi YS, Diamond JA, Yang JA, Crotty S. STAT5 is a potent negative regulator of TFH cell differentiation. J Exp Med. 2012;209(2):243-250.
34. Ballesteros-Tato A, et al. Interleukin-2 inhibits germinal center formation by limiting T fol-licular helper cell differentiation. Immunity. 2012;36(5):847-856.
35. Lowe CE, et al. Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet. 2007;39(9):1074-1082.
36. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447(7145):661-678.
37. Todd JA, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39(7):857-864.
38. Dendrou CA, et al. Cell-specific protein pheno-types for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet. 2009;41(9):1011-1015.
39. Long SA, et al. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects. Diabetes. 2010;59(2):407-415.
40. Garg G, et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T-cell function. J Immunol. 2012;188(9):4644-4653.
41. Ma CS, et al. Early commitment of naive human CD4(+) T-cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol. 2009;87(8):590-600.
42. Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG. Viral persistence redirects CD4 T-cell differentiation toward T follicu-lar helper cells. J Exp Med. 2011;208(5):987-999.
43. Baumjohann D, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38(3):596-605.
44. Silva DG, et al. Anti-islet autoantibodies trigger autoimmune diabetes in the presence of an increased frequency of islet-reactive CD4 T-cells. Diabetes. 2011;60(8):2102-2111.
45. Nakayamada S, et al. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity. 2011;35(6):919-931.
46. Oestreich KJ, Mohn SE, Weinmann AS. Molecular mechanisms that control the expression and activity of Bcl-6 in TH1 cells to regulate flexibility with a TFH-like gene profile. Nat Immunol. 2012;13(4):405-411.
47. Yu L, et al. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A. 2000;97(4):1701-1706.
48. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest. 2001;108(9):1247-1252.
49. Weber JP, Fuhrmann F, Hutloff A. T-follicular helper cells survive as long-term memory cells. Eur J Immunol. 2012;42(8):1981-1988.
50. Choi YS, et al. Bcl6 expressing follicular helper CD4 T-cells are fate committed early and have the capacity to form memory. J Immunol. 2013;190(8):4014-4026.
51. Barr T, Gray D. T(FH) memory: more or less T(FH)? Eur J Immunol. 2012;42(8):1977-1980.
52. Choi YS, Yang JA, Crotty S. Dynamic regulation of Bcl6 in follicular helper CD4 T (Tfh) cells. Curr Opin Immunol. 2013;25(3):366-372.
53. Hale JS, et al. Distinct memory CD4+ T-cells with commitment to T follicular helper-and T helper 1-cell lineages are generated after acute viral infection. Immunity. 2013;38(4):805-817.
54. Shulman Z, et al. T follicular helper cell dynamics in germinal centers. Science. 2013;341(6146):673-677.
55. He J, et al. Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T-cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770-781.
56. Perreau M, et al. Follicular helper T-cells serve as the major CD4 T-cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210(1):143-156.
57. Reinhardt RL, Liang HE, Locksley RM. Cytokine-secreting follicular T-cells shape the antibody repertoire. Nat Immunol. 2009;10(4):385-393.
58. Lee SK, et al. Interferon-gamma excess leads to pathogenic accumulation of follicular helper T-cells and germinal centers. Immunity. 2012;37(5):880-892.
59. Vijayanand P, et al. Interleukin-4 production by follicular helper T-cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity. 2012;36(2):175-187.
60. Harada Y, et al. The 3′ enhancer CNS2 is a critical regulator of interleukin-4-mediated humoral immunity in follicular helper T-cells. Immunity. 2012;36(2):188-200.
61. Schmitt N, et al. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity. 2009;31(1):158-169.
62. Li Q, Xu B, Michie SA, Rubins KH, Schreriber RD, McDevitt HO. Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A. 2008;105(34):12439-12444.
63. Diana J, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med. 2013;19(1):65-73.
64. Su C, Duan X, Zheng J, Liang L, Wang F, Guo L. IFN-α as an adjuvant for adenovirus-vectored FMDV subunit vaccine through improving the generation of T follicular helper cells. PLoS One. 2013;8(6):e66134.
65. Baumjohann D, et al. The microRNA cluster miR-17 approximately 92 promotes TFH cell differentiation and represses subset-inappropriate gene expression. Nat Immunol. 2013;14(8):840-848.
66. Kang SG, et al. MicroRNAs of the miR-17 approximately 92 family are critical regulators of T(FH) differentiation. Nat Immunol. 2013;14(8):849-857.
67. Kim HJ, Verbinnen B, Tang X, Lu L, Cantor H. Inhibition of follicular T-helper cells by CD8(+) regulatory T-cells is essential for self tolerance. Nature. 2010;467(7313):328-332.
68. Jiang H, et al. HLA-E-restricted regulatory CD8(+) T-cells are involved in development and control of human autoimmune type 1 diabetes. J Clin Invest. 2010;120(10):3641-3650.
69. Linterman MA, et al. Foxp3+ follicular regulatory T-cells control the germinal center response. Nat Med. 2011;17(8):975-982.
70. Chung Y, et al. Follicular regulatory T-cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011;17(8):983-988.
71. Vaeth M, et al. Follicular regulatory T-cells control humoral autoimmunity via NFAT2-regulated CXCR5 expression. J Exp Med. 2014; 211(3):545-561.
72. Locci M, et al. Human circulating PD-1(+) CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity. 2013;39(4):758-769.
73. Cubas RA, et al. Inadequate T follicular cell help impairs B cell immunity during HIV infection. Nat Med. 2013;19(4):494-499.
74. Bentebibel SE, et al. Induction of ICOS+CXCR3+ CXCR5+ TH cells correlates with antibody responses to influenza vaccination. Sci Transl Med. 2013;5(176):176ra132.
75. Kotlarz D, et al. Loss-of-function mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J Exp Med. 2013;210(3):433-443.
76. Linterman MA, et al. Follicular helper T-cells are required for systemic autoimmunity. J Exp Med. 2009;206(3):561-576.
77. Tangye SG, Ma CS, Brink R, Deenick EK. The good, the bad and the ugly-TFH cells in human health and disease. Nat Rev Immunol. 2013;13(6):412-426.
78. Gillespie KM, et al. HLA class II typing of whole genome amplified mouth swab DNA. Tissue Antigens. 2000;56(6):530-538.
79. Bonifacio E, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab. 2010;95(7):3360-3367.
80. Long AE, Gooneratne AT, Rokni S, Williams AJ, Bingley PJ. The role of autoantibodies to zinc transporter 8 in prediction of type 1 diabetes in relatives: lessons from the European Nicotinamide Diabetes Intervention Trial (ENDIT) cohort. J Clin Endocrinol Metab. 2012;97(2):632-637.
81. Wang CJ, et al. Cutting edge: cell-extrinsic immune regulation by ctla-4 expressed on conventional T-cells. J Immunol. 2012;189(3):1118-1122.